Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

2023/04/01 by L.E. Hendriks, K.M. Kerr, J. Menis +9 · 3 citations

paper · doi:10.1016/j.annonc.2022.12.009

Cited by

• 2025 Taiwan guidelines on the drug therapy of lung cancer: Advanced non-squamous cell carcinoma with actionable oncogenic drivers
• Extended molecular profiling in mesenchymal tumors: a consensus paper from the Italian Sarcoma Group
• Histamine H3 receptor: an emerging target for cancer therapy?